Brain Inflammation and Function in Alcoholism
NCT02233868 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 74
Last updated 2026-05-22
Summary
Background:
\- Brain inflammation due to high alcohol intake may affect thinking, memory, and concentration. Researchers want to measure this using positron emission tomography (PET).
Objective:
\- To study how excessive alcohol consumption affects brain function.
Eligibility:
* Adults 30-75 years old who are moderate or severe alcohol drinkers.
* Healthy volunteers.
Design:
* Participants will be screened with medical history, physical exam, interview, and blood and urine tests. Their breath will be tested for alcohol and recent smoking.
* Phase 1:
* Participants will stay in the hospital 3 days. They will have blood and heart tests and daily urine tests.
* A small plastic tube will be inserted by needle in each arm. One will go in a vein, the other in an artery.
* Participants will have 2 PET scans with 2 different radioactive compounds. Participants will lie on a bed that slides in and out of the scanner with a cap on their head.
* Participants will have magnetic resonance imaging (MRI) scans. Participants will lie in the scanner either resting with their eyes open or while performing an attention task.
* Participants will have tests of memory, attention, concentration, and thinking. They may answer questions, take tests, and perform simple actions.
* Phase 2 of the study will only be done if Phase 1 results show brain inflammation.
* Phase 2 will repeat Phase 1.
* For healthy volunteers, Phase 2 will begin 3 weeks after Phase 1.
* Other volunteers must not have alcohol for at least 3 weeks and stay in a hospital up to 4-6 weeks between Phase 1 and Phase 2. After Phase 2, they will have 5 follow-up calls over 3 months.
Conditions
- Alcohol Use Disorder (AUD)
Interventions
- OTHER
-
connectivity
Magnetic resonance imaging (MRI) scans will be done to assess brain structure, functional reactivity and functional connectivity.
- DRUG
-
neuroinflammation
The use of \[11C\]PBR28 will allow us to assess for the first time in vivo if there is neuroinflammation in the brain of alcoholics. It will also allow us to assess if it recovers with alcohol detoxification.
- OTHER
-
neurofunction
To assess regional brain glucose metabolism.
Sponsors & Collaborators
-
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
lead NIH
Principal Investigators
-
Dardo G Tomasi, Ph.D. · National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-19
- Primary Completion
- 2021-08-16
- Completion
- 2021-08-16
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Involvement of the Septal Nuclei of the Human Brain in Alcohol Use Disorder
NCT06866379 ·Status: RECRUITING ·Phase: NA
-
Clinical Intervention in Alcohol Use Disorder
NCT02168400 ·Status: COMPLETED ·Phase: NA
-
The Effect of Positive and Negative Emotions on Brain Activity in Alcoholics and Nonalcoholics
NCT00001675 ·Status: COMPLETED
-
Brain Connectivity Between Networks Implied in Inhibition and Cue-reactivity in Alcohol Use Disorder
NCT05843435 ·Status: COMPLETED
-
A Response Modulation Hypothesis of Socioemotional Processing Associated With Alcohol Use Disorder
NCT03535129 ·Status: COMPLETED ·Phase: NA
-
Metabolism in the Human Brain Following Consumption of a Keto-ester in Alcohol Use Disorder (AUD) With Proton Magnetic Resonance Spectroscopic Imaging (MRSI)
NCT05937893 ·Status: COMPLETED ·Phase: NA
-
Neurobiology of Alcohol and Nicotine Co-Addiction
NCT03338933 ·Status: COMPLETED
-
[C-11]PiB PET Imaging in Alcohol Use Disorders
NCT03746366 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism
NCT00612352 ·Status: COMPLETED ·Phase: NA
-
Neurofeedback & Alcohol Dependence
NCT02486900 ·Status: COMPLETED ·Phase: NA
-
PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
NCT06795581 ·Status: RECRUITING ·Phase: PHASE1
-
Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
NCT07027839 ·Status: RECRUITING ·Phase: PHASE1
-
Alcoholism Assessment and Treatment
NCT00106093 ·Status: COMPLETED
-
Multimodal Neuroimaging of Stress and Reward Cues to Assess Alcoholism Risk and Relapse
NCT02616094 ·Status: COMPLETED ·Phase: NA
-
Neural Mechanisms Underlying Alcohol Induced Disinhibition
NCT01097213 ·Status: COMPLETED
-
Ketamine Alcohol (in Treatment-Resistant Depression)
NCT02122562 ·Status: RECRUITING ·Phase: PHASE2
-
Ketamine/Placebo Family History Positive Study
NCT00588952 ·Status: COMPLETED ·Phase: NA
-
Serotonin in Alcoholism
NCT00011752 ·Status: COMPLETED
-
Deep Brain Stimulation for Refractory Alcoholism
NCT01798888 ·Status: WITHDRAWN ·Phase: PHASE1
-
Using Imaging to Assess Effects of THC on Brain Activity
NCT03655717 ·Status: COMPLETED ·Phase: NA
-
Neuroscience-Informed Treatment Development for Adolescent Alcohol Use
NCT03238300 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the BDNF-Val66Met Polymorphism in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal
NCT02146963 ·Status: COMPLETED
-
From Uncomplicated Alcoholism to Korsakoff's Syndrome
NCT01455207 ·Status: UNKNOWN ·Phase: NA
-
Optimisation of Functional MRI-based Neurofeedback for Alcohol Use Disorders
NCT02406456 ·Status: COMPLETED ·Phase: NA
-
Identification of Cellular and Molecular Mechanisms Involved in the Pathophysiology of Alcohol Use Disorder by Examination of Cerebrospinal Fluid
NCT06286449 ·Status: NOT_YET_RECRUITING ·Phase: NA